AMT vs LXEO · P/E 31, rev $10.64B vs $147.7M cap
American Tower Corp (AMT) versus Lexeo Therapeutics, Inc. Common Stock (LXEO) — a side-by-side from cached financials, not a winner call.
American Tower Corp (AMT) is a reit - specialty company listed on US.
Lexeo Therapeutics, Inc. Common Stock (LXEO) is a biotechnology company listed on US.
Latest reported AMT revenue for 2025-12-31 was $10.64B. Net income was $2.63B. Revenue was up 317.8% from 2024-12-31 to 2025-12-31. AMT currently screens at market cap $90.44B and trailing P/E 31.4.
LXEO does not have a complete income-statement cache yet.
AMT currently screens at market cap $90.44B and trailing P/E 31.4. LXEO currently screens at market cap $147.7M.
Not investment advice. Open the AMT and LXEO stock pages for the full models.
Not investment advice.